Results of COLUMBUS Part 2: A Phase 3 Trial of Encorafenib (ENCO) Plus Binimetinib (BINI) Versus ENCO in BRAF - Mutant MelanomaReinhard Dummer, Keith T. Flaherty, Ana Arance et al.|Journal Der Deutschen Dermatologischen Gesellschaft|2017Cited by 2